The problem of infertility has aggravated
globally with rise in advanced maternal age and various other factors. “Global
Assisted Reproductive Technology (ART) Market – In Vitro Fertilization,
Artificial Insemination and Third Party Assisted ART Market Outlook 2022”
provides an in-depth analysis of global Assisted Reproductive Technology (ART)
market overall as well as major technologies such as In Vitro Fertilization,
Artificial Insemination and Third-Party Assisted ART (Sperm donation, Egg
donation, Embryo donation and Surrogates). Market outlook for overall Assisted
Reproductive Technology (ART) market as well as aforementioned sub-segments has
been provided for the period 2017-22.
The report provides comprehensive coverage
on major industry drivers, restraints, and their impact on market growth during
the forecast period. Furthermore, the study encompasses various market specific
growth opportunities in global assisted reproductive technology market.
The
report has been segmented as following:-
Market
Segmentation
- In Vitro Fertilization
- Artificial Insemination
- Third-Party Assisted ART
Geographical
Coverage
- Global
- Americas
- Asia Pacific
- Europe, Middle East & Africa
Companies
Coverage
- Merck & Co., Inc.
- CooperSurgical, Inc.
- Irvine Scientific Sales Company, Inc.
- Vitrolife AB
- Hamilton Thorne, Inc.,
Infertility is a medical condition
characterized by inability to achieve pregnancy. The problem has aggravated in
many parts of the world underscoring the need for technological prowess to
address the issue. Advancement in medical technology has brought forth Assisted
Reproductive Technology (ART) which is acting as saviour for treatment of
infertility. ART procedures spans from Invitro Fertilization, Artificial
Insemination technologies such as Intrauterine Insemination, Intravaginal
Insemination and Intracervical Insemination to third party assisted ART.
Adoption rate of ART techniques has been increasing at fast pace globally.
Growth of global Assisted Reproductive
Technology (ART) market is primarily attributed to factors such as prevalence
of infertility, advanced maternal age, high obesity rates, rising level of
alcohol and tobacco consumption, low awareness of fertility problems and
favourable reimbursement policies. However, the market faces challenges due to
stringent regulatory norms and high treatment cost associated with treatment of
infertility. The market is characterized by leading trends such growth in
strategic alliances and technological advancement in various procedures
pertaining to treatment of infertility using ART.
The report “Global Assisted Reproductive
Technology (ART) Market – In Vitro Fertilization, Artificial Insemination and
Third Party Assisted ART Market Outlook 2022” provides in-depth analysis of the
current scenario, detailed market outlook of the global Assisted Reproductive
Technology (ART) market with coverage of major technologies such as In Vitro
Fertilization, Artificial Insemination and Third-Party Assisted ART (Sperm
donation, Egg donation, Embryo donation and Surrogates). Geographically, the
market is segmented into Americas, Asia Pacific and Europe, Middle East &
Africa. Future forecasts of ART market overall and across various sub-segments
is provided in the report till the year 2022. Furthermore, major industry
players have been prudently analysed in the competitive landscape section of
the report in order to provide key comparative insights.
Major industry players operating in the
global market include Merck & Co., Inc., CooperSurgical, Inc., Irvine
Scientific Sales Company, Inc., Vitrolife AB, Hamilton Thorne, Inc., among
others. These players are profiled herein based on attributes such as business
overview, product segments and financial analysis. It also compiles performance
comparison of aforementioned companies and other leading companies in the
segment based on various parameters in the competitive landscape section. In
totality, the report provides detailed market analysis, with relevant
forecasted data supported by key market dynamics. This information will be
helpful in evaluating opportunities in global assisted reproductive technology
market.
Spanning over 77 pages “Global
Assisted Reproductive Technology (ART) Market - In Vitro Fertilization,
Artificial Insemination and Third Party Assisted ART Market Outlook 2022” report
covers Executive Summary, Research Methodology, Assisted Reproductive
Technology: Introduction, Assisted Reproductive Technology (ART) Market
Analysis, Assisted Reproductive Technology (ART) Market Segmentation, Assisted
Reproductive Technology (ART) Regional Analysis, Assisted Reproductive
Technology (ART) Market Dynamics, Competitive Landscape, Company Profiles. This
report Covered Companies - Merck & Co., Inc., CooperSurgical, Inc., Irvine
Scientific Sales Company, Inc., Vitrolife AB, Hamilton Thorne, Inc.
Please visit this link for more details: http://mrr.cm/UYU
For related reports please visit: Assisted Reproductive Technology Market Research Reports
Find all Pharma
and Healthcare Reports at: https://www.marketresearchreports.com/pharma-healthcare
No comments:
Post a Comment
Note: only a member of this blog may post a comment.